Minodronic acid

Overview

Minodronic acid (YM-529) is an FPP synthase inhibitor with an IC 50 of 3 nM, and also an antagonist of P2X2/3 receptors with an IC 50 of 62.7 μM. Minodronic acid induces tumor cell apoptosis and inhibits cell growth. Minodronic acid also suppresses bone resorption. Minodronic acid can be used in research related to osteoporosis and cancer .

Application

Products | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Mineral Metabolism | Products > Disease Areas > Bladder Cancer | Products > Disease Areas > Urogenital Cancer | Products > Disease Areas > Osteoporosis | Products > Disease Areas > Cancer | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > P2X Receptor | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Farnesyl Transferase

Product Information

• Catalog No.: HY-16322
• CAS No.: 180064-38-4
• Molecular Formula: C9H12N2O7P2
• Molecular Weight: 322.15
• Purity: 99.67%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: 2 mg/mL (6.21 mM); Clear solution; Need ultrasonic
• Availability: In-stock

Source

Original product source